Adaptimmune is a clinical stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company\'s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T cell platform enables the engineering of T cells to…
Adaptimmune is a clinical stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company\'s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T cell platform enables the engineering of T cells to…